1-3 of 3
Marta Martinez Diez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unveiling the Mechanism of Lurbinectedin’s Action and Its Potential in Combination Therapies in Small Cell Lung Cancer

Antonio Calles, Emiliano Calvo, Gema Santamaría Nuñez, Federico Costanzo, María José Guillén, Marta Martinez Diez, Aparna Gupta, Carmen Cuevas, Jean-Marc Egly, Pablo Avilés
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF12.
https://doi.org/10.1158/1535-7163.MCT-24-0050
Published: 30 December 2024
View article titled, Unveiling the Mechanism of Lurbinectedin’s Action and Its Potential in Combination Therapies in Small Cell Lung Cancer
Open the PDF for Unveiling the Mechanism of Lurbinectedin’s Action and Its Potential in Combination Therapies in Small Cell Lung Cancer in another window
Journal Articles

Abstract A177: Mode of action of PM060184, a new interfacial microtubule inhibitor of marine origin.

Marta Martínez-Diez, Juan Fernando Martínez-Leal, Luis F. Garcia-Fernandez, Carlos M. Galmarini
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A177.
https://doi.org/10.1158/1535-7163.TARG-13-A177
Published: 01 November 2013
View article titled, Abstract A177: Mode of action of PM060184, a new interfacial microtubule inhibitor of marine origin.
Journal Articles

Abstract A173: The new marine derived tubulin binding agent PM060184 shows potent antitumor activity in vivo against multidrug resistant, Pgp expressing tumors.

Pablo M. Aviles, Maria José Guillen, Mandy Palomares, Praxedes Nuñez, Marta Martinez-Diez, Juan Fernando Martínez-Leal, Luis Francisco García-Fernández, Carlos M. Galmarini
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A173.
https://doi.org/10.1158/1535-7163.TARG-13-A173
Published: 01 November 2013
View article titled, Abstract A173: The new marine derived tubulin binding agent PM060184 shows potent antitumor activity <em>in vivo</em> against multidrug resistant, Pgp expressing tumors.